Baidu
map
REPROD BIOMED ONLINE 润色咨询

REPRODUCTIVE BIOMEDICINE ONLINE

出版年份：2000 年文章数：2587 投稿命中率： 开通期刊会员，数据随心看

出版周期：Monthly 自引率：9.3% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2239942, encodeId=effd2239942d9, content=不收MR文章 New analytical methodologies continue to be introduced in our field. MR is a potentially powerful method that is proposed to strengthen causal inferences derived from observational epidemiological data and evidence provided by genetic variants. However, as with some other analytic methodologies, it is subject to potential biases that can limit its validity when seeking a causative interpretation of results. Until this methodology has been shown to be sufficiently robust and more readily assessed, RBMO will not be considering studies derived from this approach., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Fri Nov 29 17:21:10 CST 2024, time=2024-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=859008, encodeId=f69b85900865, content=效率太差了；<br> 2020-2-15 投稿；2-25 外审；3-4 外审更新；3-13 再次更新，with editor; 马上一个月了，编辑就是做不出决定。。。 被隔离了么= = , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07165414144, createdName=ms4573613856522007, createdTime=Thu Apr 02 16:58:07 CST 2020, time=2020-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887816, encodeId=fe0388e81689, content=请问前辈，版面费贵不贵？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=038c5420018, createdName=ms7000001329504099, createdTime=Thu Sep 24 01:49:16 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161514, encodeId=64c821615147d, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向：胚胎<br>经验分享：送审两周就回意见了，40个超级大问题，给了一个月修稿时间。非常艰难地极限完成了，几乎是把原始数据全部重新分析一遍。再给回去，两个审稿人都非常满意，给了Very well done的评语，两周接收。从投稿到接收只花了三个月，算是很快的。感觉收获非常大，审稿人问问题很专业，第一次做临床研究，初稿本身有些基础知识的错误，审稿人都非常耐心地一一指出，编辑给了回复和修改的机会，感恩。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8f72518204, createdName=124d389fm31暂无昵称, createdTime=Sun Oct 08 11:09:01 CST 2023, time=2023-10-08, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=530204, encodeId=380a53020468, content=11月30号投的，第二天with editor，第四天 submitted to the journal,期待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=476, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=52241720794, createdName=飞霄, createdTime=Sun Dec 04 18:59:00 CST 2016, time=2016-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098037, encodeId=5cfc109803e2c, content=摘要中一定要加入研究目标么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098038, encodeId=1a90109803887, content=摘要撰写有什么套路？有没有模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948455, encodeId=095894845551, content=instructions for authoers一直打不开，不知道怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=21b55107564, createdName=14609b34m61暂无昵称, createdTime=Mon Mar 15 20:45:11 CST 2021, time=2021-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=859050, encodeId=dc9c85905090, content=审稿速度:2.0<br>经验分享：2-15 投稿 4-3 被拒<br> 两个审稿 一个认可 一个拒稿 醉了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1f95413964, createdName=ms3270320448344871, createdTime=Fri Apr 03 19:18:18 CST 2020, time=2020-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=857851, encodeId=58d785e851a4, content=审稿速度:1.0<br>经验分享：投稿外泌体测序文章，5天拒稿 效率还可以 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13ef5414127, createdName=ms5624929764890046, createdTime=Thu Feb 27 15:51:21 CST 2020, time=2020-02-27, status=1, ipAttribution=)]
    2024-11-29 匿名用户

    不收MR文章 New analytical methodologies continue to be introduced in our field. MR is a potentially powerful method that is proposed to strengthen causal inferences derived from observational epidemiological data and evidence provided by genetic variants. However, as with some other analytic methodologies, it is subject to potential biases that can limit its validity when seeking a causative interpretation of results. Until this methodology has been shown to be sufficiently robust and more readily assessed, RBMO will not be considering studies derived from this approach.

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2239942, encodeId=effd2239942d9, content=不收MR文章 New analytical methodologies continue to be introduced in our field. MR is a potentially powerful method that is proposed to strengthen causal inferences derived from observational epidemiological data and evidence provided by genetic variants. However, as with some other analytic methodologies, it is subject to potential biases that can limit its validity when seeking a causative interpretation of results. Until this methodology has been shown to be sufficiently robust and more readily assessed, RBMO will not be considering studies derived from this approach., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Fri Nov 29 17:21:10 CST 2024, time=2024-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=859008, encodeId=f69b85900865, content=效率太差了；<br> 2020-2-15 投稿；2-25 外审；3-4 外审更新；3-13 再次更新，with editor; 马上一个月了，编辑就是做不出决定。。。 被隔离了么= = , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07165414144, createdName=ms4573613856522007, createdTime=Thu Apr 02 16:58:07 CST 2020, time=2020-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887816, encodeId=fe0388e81689, content=请问前辈，版面费贵不贵？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=038c5420018, createdName=ms7000001329504099, createdTime=Thu Sep 24 01:49:16 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161514, encodeId=64c821615147d, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向：胚胎<br>经验分享：送审两周就回意见了，40个超级大问题，给了一个月修稿时间。非常艰难地极限完成了，几乎是把原始数据全部重新分析一遍。再给回去，两个审稿人都非常满意，给了Very well done的评语，两周接收。从投稿到接收只花了三个月，算是很快的。感觉收获非常大，审稿人问问题很专业，第一次做临床研究，初稿本身有些基础知识的错误，审稿人都非常耐心地一一指出，编辑给了回复和修改的机会，感恩。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8f72518204, createdName=124d389fm31暂无昵称, createdTime=Sun Oct 08 11:09:01 CST 2023, time=2023-10-08, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=530204, encodeId=380a53020468, content=11月30号投的，第二天with editor，第四天 submitted to the journal,期待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=476, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=52241720794, createdName=飞霄, createdTime=Sun Dec 04 18:59:00 CST 2016, time=2016-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098037, encodeId=5cfc109803e2c, content=摘要中一定要加入研究目标么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098038, encodeId=1a90109803887, content=摘要撰写有什么套路？有没有模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948455, encodeId=095894845551, content=instructions for authoers一直打不开，不知道怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=21b55107564, createdName=14609b34m61暂无昵称, createdTime=Mon Mar 15 20:45:11 CST 2021, time=2021-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=859050, encodeId=dc9c85905090, content=审稿速度:2.0<br>经验分享：2-15 投稿 4-3 被拒<br> 两个审稿 一个认可 一个拒稿 醉了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1f95413964, createdName=ms3270320448344871, createdTime=Fri Apr 03 19:18:18 CST 2020, time=2020-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=857851, encodeId=58d785e851a4, content=审稿速度:1.0<br>经验分享：投稿外泌体测序文章，5天拒稿 效率还可以 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13ef5414127, createdName=ms5624929764890046, createdTime=Thu Feb 27 15:51:21 CST 2020, time=2020-02-27, status=1, ipAttribution=)]
    2020-04-02 ms4573613856522007

    效率太差了；
    2020-2-15 投稿；2-25 外审；3-4 外审更新；3-13 再次更新，with editor; 马上一个月了，编辑就是做不出决定。。。 被隔离了么= =

    4

    展开4条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2239942, encodeId=effd2239942d9, content=不收MR文章 New analytical methodologies continue to be introduced in our field. MR is a potentially powerful method that is proposed to strengthen causal inferences derived from observational epidemiological data and evidence provided by genetic variants. However, as with some other analytic methodologies, it is subject to potential biases that can limit its validity when seeking a causative interpretation of results. Until this methodology has been shown to be sufficiently robust and more readily assessed, RBMO will not be considering studies derived from this approach., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Fri Nov 29 17:21:10 CST 2024, time=2024-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=859008, encodeId=f69b85900865, content=效率太差了；<br> 2020-2-15 投稿；2-25 外审；3-4 外审更新；3-13 再次更新，with editor; 马上一个月了，编辑就是做不出决定。。。 被隔离了么= = , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07165414144, createdName=ms4573613856522007, createdTime=Thu Apr 02 16:58:07 CST 2020, time=2020-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887816, encodeId=fe0388e81689, content=请问前辈，版面费贵不贵？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=038c5420018, createdName=ms7000001329504099, createdTime=Thu Sep 24 01:49:16 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161514, encodeId=64c821615147d, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向：胚胎<br>经验分享：送审两周就回意见了，40个超级大问题，给了一个月修稿时间。非常艰难地极限完成了，几乎是把原始数据全部重新分析一遍。再给回去，两个审稿人都非常满意，给了Very well done的评语，两周接收。从投稿到接收只花了三个月，算是很快的。感觉收获非常大，审稿人问问题很专业，第一次做临床研究，初稿本身有些基础知识的错误，审稿人都非常耐心地一一指出，编辑给了回复和修改的机会，感恩。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8f72518204, createdName=124d389fm31暂无昵称, createdTime=Sun Oct 08 11:09:01 CST 2023, time=2023-10-08, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=530204, encodeId=380a53020468, content=11月30号投的，第二天with editor，第四天 submitted to the journal,期待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=476, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=52241720794, createdName=飞霄, createdTime=Sun Dec 04 18:59:00 CST 2016, time=2016-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098037, encodeId=5cfc109803e2c, content=摘要中一定要加入研究目标么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098038, encodeId=1a90109803887, content=摘要撰写有什么套路？有没有模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948455, encodeId=095894845551, content=instructions for authoers一直打不开，不知道怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=21b55107564, createdName=14609b34m61暂无昵称, createdTime=Mon Mar 15 20:45:11 CST 2021, time=2021-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=859050, encodeId=dc9c85905090, content=审稿速度:2.0<br>经验分享：2-15 投稿 4-3 被拒<br> 两个审稿 一个认可 一个拒稿 醉了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1f95413964, createdName=ms3270320448344871, createdTime=Fri Apr 03 19:18:18 CST 2020, time=2020-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=857851, encodeId=58d785e851a4, content=审稿速度:1.0<br>经验分享：投稿外泌体测序文章，5天拒稿 效率还可以 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13ef5414127, createdName=ms5624929764890046, createdTime=Thu Feb 27 15:51:21 CST 2020, time=2020-02-27, status=1, ipAttribution=)]
    2020-09-24 ms7000001329504099

    请问前辈，版面费贵不贵？

    2

    展开2条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2239942, encodeId=effd2239942d9, content=不收MR文章 New analytical methodologies continue to be introduced in our field. MR is a potentially powerful method that is proposed to strengthen causal inferences derived from observational epidemiological data and evidence provided by genetic variants. However, as with some other analytic methodologies, it is subject to potential biases that can limit its validity when seeking a causative interpretation of results. Until this methodology has been shown to be sufficiently robust and more readily assessed, RBMO will not be considering studies derived from this approach., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Fri Nov 29 17:21:10 CST 2024, time=2024-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=859008, encodeId=f69b85900865, content=效率太差了；<br> 2020-2-15 投稿；2-25 外审；3-4 外审更新；3-13 再次更新，with editor; 马上一个月了，编辑就是做不出决定。。。 被隔离了么= = , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07165414144, createdName=ms4573613856522007, createdTime=Thu Apr 02 16:58:07 CST 2020, time=2020-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887816, encodeId=fe0388e81689, content=请问前辈，版面费贵不贵？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=038c5420018, createdName=ms7000001329504099, createdTime=Thu Sep 24 01:49:16 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161514, encodeId=64c821615147d, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向：胚胎<br>经验分享：送审两周就回意见了，40个超级大问题，给了一个月修稿时间。非常艰难地极限完成了，几乎是把原始数据全部重新分析一遍。再给回去，两个审稿人都非常满意，给了Very well done的评语，两周接收。从投稿到接收只花了三个月，算是很快的。感觉收获非常大，审稿人问问题很专业，第一次做临床研究，初稿本身有些基础知识的错误，审稿人都非常耐心地一一指出，编辑给了回复和修改的机会，感恩。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8f72518204, createdName=124d389fm31暂无昵称, createdTime=Sun Oct 08 11:09:01 CST 2023, time=2023-10-08, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=530204, encodeId=380a53020468, content=11月30号投的，第二天with editor，第四天 submitted to the journal,期待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=476, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=52241720794, createdName=飞霄, createdTime=Sun Dec 04 18:59:00 CST 2016, time=2016-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098037, encodeId=5cfc109803e2c, content=摘要中一定要加入研究目标么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098038, encodeId=1a90109803887, content=摘要撰写有什么套路？有没有模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948455, encodeId=095894845551, content=instructions for authoers一直打不开，不知道怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=21b55107564, createdName=14609b34m61暂无昵称, createdTime=Mon Mar 15 20:45:11 CST 2021, time=2021-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=859050, encodeId=dc9c85905090, content=审稿速度:2.0<br>经验分享：2-15 投稿 4-3 被拒<br> 两个审稿 一个认可 一个拒稿 醉了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1f95413964, createdName=ms3270320448344871, createdTime=Fri Apr 03 19:18:18 CST 2020, time=2020-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=857851, encodeId=58d785e851a4, content=审稿速度:1.0<br>经验分享：投稿外泌体测序文章，5天拒稿 效率还可以 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13ef5414127, createdName=ms5624929764890046, createdTime=Thu Feb 27 15:51:21 CST 2020, time=2020-02-27, status=1, ipAttribution=)]
    2023-10-08 124d389fm31暂无昵称 来自湖北省

    审稿速度:3.0 | 投稿命中率:25.0
    偏重的研究方向：胚胎
    经验分享：送审两周就回意见了，40个超级大问题，给了一个月修稿时间。非常艰难地极限完成了，几乎是把原始数据全部重新分析一遍。再给回去，两个审稿人都非常满意，给了Very well done的评语，两周接收。从投稿到接收只花了三个月，算是很快的。感觉收获非常大，审稿人问问题很专业，第一次做临床研究，初稿本身有些基础知识的错误，审稿人都非常耐心地一一指出，编辑给了回复和修改的机会，感恩。

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2239942, encodeId=effd2239942d9, content=不收MR文章 New analytical methodologies continue to be introduced in our field. MR is a potentially powerful method that is proposed to strengthen causal inferences derived from observational epidemiological data and evidence provided by genetic variants. However, as with some other analytic methodologies, it is subject to potential biases that can limit its validity when seeking a causative interpretation of results. Until this methodology has been shown to be sufficiently robust and more readily assessed, RBMO will not be considering studies derived from this approach., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Fri Nov 29 17:21:10 CST 2024, time=2024-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=859008, encodeId=f69b85900865, content=效率太差了；<br> 2020-2-15 投稿；2-25 外审；3-4 外审更新；3-13 再次更新，with editor; 马上一个月了，编辑就是做不出决定。。。 被隔离了么= = , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07165414144, createdName=ms4573613856522007, createdTime=Thu Apr 02 16:58:07 CST 2020, time=2020-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887816, encodeId=fe0388e81689, content=请问前辈，版面费贵不贵？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=038c5420018, createdName=ms7000001329504099, createdTime=Thu Sep 24 01:49:16 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161514, encodeId=64c821615147d, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向：胚胎<br>经验分享：送审两周就回意见了，40个超级大问题，给了一个月修稿时间。非常艰难地极限完成了，几乎是把原始数据全部重新分析一遍。再给回去，两个审稿人都非常满意，给了Very well done的评语，两周接收。从投稿到接收只花了三个月，算是很快的。感觉收获非常大，审稿人问问题很专业，第一次做临床研究，初稿本身有些基础知识的错误，审稿人都非常耐心地一一指出，编辑给了回复和修改的机会，感恩。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8f72518204, createdName=124d389fm31暂无昵称, createdTime=Sun Oct 08 11:09:01 CST 2023, time=2023-10-08, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=530204, encodeId=380a53020468, content=11月30号投的，第二天with editor，第四天 submitted to the journal,期待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=476, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=52241720794, createdName=飞霄, createdTime=Sun Dec 04 18:59:00 CST 2016, time=2016-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098037, encodeId=5cfc109803e2c, content=摘要中一定要加入研究目标么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098038, encodeId=1a90109803887, content=摘要撰写有什么套路？有没有模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948455, encodeId=095894845551, content=instructions for authoers一直打不开，不知道怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=21b55107564, createdName=14609b34m61暂无昵称, createdTime=Mon Mar 15 20:45:11 CST 2021, time=2021-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=859050, encodeId=dc9c85905090, content=审稿速度:2.0<br>经验分享：2-15 投稿 4-3 被拒<br> 两个审稿 一个认可 一个拒稿 醉了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1f95413964, createdName=ms3270320448344871, createdTime=Fri Apr 03 19:18:18 CST 2020, time=2020-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=857851, encodeId=58d785e851a4, content=审稿速度:1.0<br>经验分享：投稿外泌体测序文章，5天拒稿 效率还可以 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13ef5414127, createdName=ms5624929764890046, createdTime=Thu Feb 27 15:51:21 CST 2020, time=2020-02-27, status=1, ipAttribution=)]
    2016-12-04 飞霄

    11月30号投的，第二天with editor，第四天 submitted to the journal,期待中

    1

    展开1条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2239942, encodeId=effd2239942d9, content=不收MR文章 New analytical methodologies continue to be introduced in our field. MR is a potentially powerful method that is proposed to strengthen causal inferences derived from observational epidemiological data and evidence provided by genetic variants. However, as with some other analytic methodologies, it is subject to potential biases that can limit its validity when seeking a causative interpretation of results. Until this methodology has been shown to be sufficiently robust and more readily assessed, RBMO will not be considering studies derived from this approach., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Fri Nov 29 17:21:10 CST 2024, time=2024-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=859008, encodeId=f69b85900865, content=效率太差了；<br> 2020-2-15 投稿；2-25 外审；3-4 外审更新；3-13 再次更新，with editor; 马上一个月了，编辑就是做不出决定。。。 被隔离了么= = , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07165414144, createdName=ms4573613856522007, createdTime=Thu Apr 02 16:58:07 CST 2020, time=2020-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887816, encodeId=fe0388e81689, content=请问前辈，版面费贵不贵？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=038c5420018, createdName=ms7000001329504099, createdTime=Thu Sep 24 01:49:16 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161514, encodeId=64c821615147d, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向：胚胎<br>经验分享：送审两周就回意见了，40个超级大问题，给了一个月修稿时间。非常艰难地极限完成了，几乎是把原始数据全部重新分析一遍。再给回去，两个审稿人都非常满意，给了Very well done的评语，两周接收。从投稿到接收只花了三个月，算是很快的。感觉收获非常大，审稿人问问题很专业，第一次做临床研究，初稿本身有些基础知识的错误，审稿人都非常耐心地一一指出，编辑给了回复和修改的机会，感恩。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8f72518204, createdName=124d389fm31暂无昵称, createdTime=Sun Oct 08 11:09:01 CST 2023, time=2023-10-08, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=530204, encodeId=380a53020468, content=11月30号投的，第二天with editor，第四天 submitted to the journal,期待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=476, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=52241720794, createdName=飞霄, createdTime=Sun Dec 04 18:59:00 CST 2016, time=2016-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098037, encodeId=5cfc109803e2c, content=摘要中一定要加入研究目标么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098038, encodeId=1a90109803887, content=摘要撰写有什么套路？有没有模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948455, encodeId=095894845551, content=instructions for authoers一直打不开，不知道怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=21b55107564, createdName=14609b34m61暂无昵称, createdTime=Mon Mar 15 20:45:11 CST 2021, time=2021-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=859050, encodeId=dc9c85905090, content=审稿速度:2.0<br>经验分享：2-15 投稿 4-3 被拒<br> 两个审稿 一个认可 一个拒稿 醉了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1f95413964, createdName=ms3270320448344871, createdTime=Fri Apr 03 19:18:18 CST 2020, time=2020-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=857851, encodeId=58d785e851a4, content=审稿速度:1.0<br>经验分享：投稿外泌体测序文章，5天拒稿 效率还可以 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13ef5414127, createdName=ms5624929764890046, createdTime=Thu Feb 27 15:51:21 CST 2020, time=2020-02-27, status=1, ipAttribution=)]
    2021-12-28 Gym璨烨

    摘要中一定要加入研究目标么？

    1

    展开1条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2239942, encodeId=effd2239942d9, content=不收MR文章 New analytical methodologies continue to be introduced in our field. MR is a potentially powerful method that is proposed to strengthen causal inferences derived from observational epidemiological data and evidence provided by genetic variants. However, as with some other analytic methodologies, it is subject to potential biases that can limit its validity when seeking a causative interpretation of results. Until this methodology has been shown to be sufficiently robust and more readily assessed, RBMO will not be considering studies derived from this approach., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Fri Nov 29 17:21:10 CST 2024, time=2024-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=859008, encodeId=f69b85900865, content=效率太差了；<br> 2020-2-15 投稿；2-25 外审；3-4 外审更新；3-13 再次更新，with editor; 马上一个月了，编辑就是做不出决定。。。 被隔离了么= = , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07165414144, createdName=ms4573613856522007, createdTime=Thu Apr 02 16:58:07 CST 2020, time=2020-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887816, encodeId=fe0388e81689, content=请问前辈，版面费贵不贵？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=038c5420018, createdName=ms7000001329504099, createdTime=Thu Sep 24 01:49:16 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161514, encodeId=64c821615147d, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向：胚胎<br>经验分享：送审两周就回意见了，40个超级大问题，给了一个月修稿时间。非常艰难地极限完成了，几乎是把原始数据全部重新分析一遍。再给回去，两个审稿人都非常满意，给了Very well done的评语，两周接收。从投稿到接收只花了三个月，算是很快的。感觉收获非常大，审稿人问问题很专业，第一次做临床研究，初稿本身有些基础知识的错误，审稿人都非常耐心地一一指出，编辑给了回复和修改的机会，感恩。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8f72518204, createdName=124d389fm31暂无昵称, createdTime=Sun Oct 08 11:09:01 CST 2023, time=2023-10-08, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=530204, encodeId=380a53020468, content=11月30号投的，第二天with editor，第四天 submitted to the journal,期待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=476, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=52241720794, createdName=飞霄, createdTime=Sun Dec 04 18:59:00 CST 2016, time=2016-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098037, encodeId=5cfc109803e2c, content=摘要中一定要加入研究目标么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098038, encodeId=1a90109803887, content=摘要撰写有什么套路？有没有模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948455, encodeId=095894845551, content=instructions for authoers一直打不开，不知道怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=21b55107564, createdName=14609b34m61暂无昵称, createdTime=Mon Mar 15 20:45:11 CST 2021, time=2021-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=859050, encodeId=dc9c85905090, content=审稿速度:2.0<br>经验分享：2-15 投稿 4-3 被拒<br> 两个审稿 一个认可 一个拒稿 醉了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1f95413964, createdName=ms3270320448344871, createdTime=Fri Apr 03 19:18:18 CST 2020, time=2020-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=857851, encodeId=58d785e851a4, content=审稿速度:1.0<br>经验分享：投稿外泌体测序文章，5天拒稿 效率还可以 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13ef5414127, createdName=ms5624929764890046, createdTime=Thu Feb 27 15:51:21 CST 2020, time=2020-02-27, status=1, ipAttribution=)]
    2021-12-28 小动量

    摘要撰写有什么套路？有没有模板？

    1

    展开1条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2239942, encodeId=effd2239942d9, content=不收MR文章 New analytical methodologies continue to be introduced in our field. MR is a potentially powerful method that is proposed to strengthen causal inferences derived from observational epidemiological data and evidence provided by genetic variants. However, as with some other analytic methodologies, it is subject to potential biases that can limit its validity when seeking a causative interpretation of results. Until this methodology has been shown to be sufficiently robust and more readily assessed, RBMO will not be considering studies derived from this approach., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Fri Nov 29 17:21:10 CST 2024, time=2024-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=859008, encodeId=f69b85900865, content=效率太差了；<br> 2020-2-15 投稿；2-25 外审；3-4 外审更新；3-13 再次更新，with editor; 马上一个月了，编辑就是做不出决定。。。 被隔离了么= = , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07165414144, createdName=ms4573613856522007, createdTime=Thu Apr 02 16:58:07 CST 2020, time=2020-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887816, encodeId=fe0388e81689, content=请问前辈，版面费贵不贵？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=038c5420018, createdName=ms7000001329504099, createdTime=Thu Sep 24 01:49:16 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161514, encodeId=64c821615147d, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向：胚胎<br>经验分享：送审两周就回意见了，40个超级大问题，给了一个月修稿时间。非常艰难地极限完成了，几乎是把原始数据全部重新分析一遍。再给回去，两个审稿人都非常满意，给了Very well done的评语，两周接收。从投稿到接收只花了三个月，算是很快的。感觉收获非常大，审稿人问问题很专业，第一次做临床研究，初稿本身有些基础知识的错误，审稿人都非常耐心地一一指出，编辑给了回复和修改的机会，感恩。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8f72518204, createdName=124d389fm31暂无昵称, createdTime=Sun Oct 08 11:09:01 CST 2023, time=2023-10-08, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=530204, encodeId=380a53020468, content=11月30号投的，第二天with editor，第四天 submitted to the journal,期待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=476, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=52241720794, createdName=飞霄, createdTime=Sun Dec 04 18:59:00 CST 2016, time=2016-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098037, encodeId=5cfc109803e2c, content=摘要中一定要加入研究目标么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098038, encodeId=1a90109803887, content=摘要撰写有什么套路？有没有模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948455, encodeId=095894845551, content=instructions for authoers一直打不开，不知道怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=21b55107564, createdName=14609b34m61暂无昵称, createdTime=Mon Mar 15 20:45:11 CST 2021, time=2021-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=859050, encodeId=dc9c85905090, content=审稿速度:2.0<br>经验分享：2-15 投稿 4-3 被拒<br> 两个审稿 一个认可 一个拒稿 醉了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1f95413964, createdName=ms3270320448344871, createdTime=Fri Apr 03 19:18:18 CST 2020, time=2020-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=857851, encodeId=58d785e851a4, content=审稿速度:1.0<br>经验分享：投稿外泌体测序文章，5天拒稿 效率还可以 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13ef5414127, createdName=ms5624929764890046, createdTime=Thu Feb 27 15:51:21 CST 2020, time=2020-02-27, status=1, ipAttribution=)]
    2021-03-15 14609b34m61暂无昵称

    instructions for authoers一直打不开，不知道怎么回事

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=2239942, encodeId=effd2239942d9, content=不收MR文章 New analytical methodologies continue to be introduced in our field. MR is a potentially powerful method that is proposed to strengthen causal inferences derived from observational epidemiological data and evidence provided by genetic variants. However, as with some other analytic methodologies, it is subject to potential biases that can limit its validity when seeking a causative interpretation of results. Until this methodology has been shown to be sufficiently robust and more readily assessed, RBMO will not be considering studies derived from this approach., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Fri Nov 29 17:21:10 CST 2024, time=2024-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=859008, encodeId=f69b85900865, content=效率太差了；<br> 2020-2-15 投稿；2-25 外审；3-4 外审更新；3-13 再次更新，with editor; 马上一个月了，编辑就是做不出决定。。。 被隔离了么= = , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07165414144, createdName=ms4573613856522007, createdTime=Thu Apr 02 16:58:07 CST 2020, time=2020-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887816, encodeId=fe0388e81689, content=请问前辈，版面费贵不贵？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=038c5420018, createdName=ms7000001329504099, createdTime=Thu Sep 24 01:49:16 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161514, encodeId=64c821615147d, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向：胚胎<br>经验分享：送审两周就回意见了，40个超级大问题，给了一个月修稿时间。非常艰难地极限完成了，几乎是把原始数据全部重新分析一遍。再给回去，两个审稿人都非常满意，给了Very well done的评语，两周接收。从投稿到接收只花了三个月，算是很快的。感觉收获非常大，审稿人问问题很专业，第一次做临床研究，初稿本身有些基础知识的错误，审稿人都非常耐心地一一指出，编辑给了回复和修改的机会，感恩。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8f72518204, createdName=124d389fm31暂无昵称, createdTime=Sun Oct 08 11:09:01 CST 2023, time=2023-10-08, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=530204, encodeId=380a53020468, content=11月30号投的，第二天with editor，第四天 submitted to the journal,期待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=476, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=52241720794, createdName=飞霄, createdTime=Sun Dec 04 18:59:00 CST 2016, time=2016-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098037, encodeId=5cfc109803e2c, content=摘要中一定要加入研究目标么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098038, encodeId=1a90109803887, content=摘要撰写有什么套路？有没有模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948455, encodeId=095894845551, content=instructions for authoers一直打不开，不知道怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=21b55107564, createdName=14609b34m61暂无昵称, createdTime=Mon Mar 15 20:45:11 CST 2021, time=2021-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=859050, encodeId=dc9c85905090, content=审稿速度:2.0<br>经验分享：2-15 投稿 4-3 被拒<br> 两个审稿 一个认可 一个拒稿 醉了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1f95413964, createdName=ms3270320448344871, createdTime=Fri Apr 03 19:18:18 CST 2020, time=2020-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=857851, encodeId=58d785e851a4, content=审稿速度:1.0<br>经验分享：投稿外泌体测序文章，5天拒稿 效率还可以 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13ef5414127, createdName=ms5624929764890046, createdTime=Thu Feb 27 15:51:21 CST 2020, time=2020-02-27, status=1, ipAttribution=)]
    2020-04-03 ms3270320448344871

    审稿速度:2.0
    经验分享：2-15 投稿 4-3 被拒
    两个审稿 一个认可 一个拒稿 醉了

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=2239942, encodeId=effd2239942d9, content=不收MR文章 New analytical methodologies continue to be introduced in our field. MR is a potentially powerful method that is proposed to strengthen causal inferences derived from observational epidemiological data and evidence provided by genetic variants. However, as with some other analytic methodologies, it is subject to potential biases that can limit its validity when seeking a causative interpretation of results. Until this methodology has been shown to be sufficiently robust and more readily assessed, RBMO will not be considering studies derived from this approach., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Fri Nov 29 17:21:10 CST 2024, time=2024-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=859008, encodeId=f69b85900865, content=效率太差了；<br> 2020-2-15 投稿；2-25 外审；3-4 外审更新；3-13 再次更新，with editor; 马上一个月了，编辑就是做不出决定。。。 被隔离了么= = , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07165414144, createdName=ms4573613856522007, createdTime=Thu Apr 02 16:58:07 CST 2020, time=2020-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887816, encodeId=fe0388e81689, content=请问前辈，版面费贵不贵？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=038c5420018, createdName=ms7000001329504099, createdTime=Thu Sep 24 01:49:16 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161514, encodeId=64c821615147d, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向：胚胎<br>经验分享：送审两周就回意见了，40个超级大问题，给了一个月修稿时间。非常艰难地极限完成了，几乎是把原始数据全部重新分析一遍。再给回去，两个审稿人都非常满意，给了Very well done的评语，两周接收。从投稿到接收只花了三个月，算是很快的。感觉收获非常大，审稿人问问题很专业，第一次做临床研究，初稿本身有些基础知识的错误，审稿人都非常耐心地一一指出，编辑给了回复和修改的机会，感恩。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8f72518204, createdName=124d389fm31暂无昵称, createdTime=Sun Oct 08 11:09:01 CST 2023, time=2023-10-08, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=530204, encodeId=380a53020468, content=11月30号投的，第二天with editor，第四天 submitted to the journal,期待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=476, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=52241720794, createdName=飞霄, createdTime=Sun Dec 04 18:59:00 CST 2016, time=2016-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098037, encodeId=5cfc109803e2c, content=摘要中一定要加入研究目标么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098038, encodeId=1a90109803887, content=摘要撰写有什么套路？有没有模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948455, encodeId=095894845551, content=instructions for authoers一直打不开，不知道怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=21b55107564, createdName=14609b34m61暂无昵称, createdTime=Mon Mar 15 20:45:11 CST 2021, time=2021-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=859050, encodeId=dc9c85905090, content=审稿速度:2.0<br>经验分享：2-15 投稿 4-3 被拒<br> 两个审稿 一个认可 一个拒稿 醉了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1f95413964, createdName=ms3270320448344871, createdTime=Fri Apr 03 19:18:18 CST 2020, time=2020-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=857851, encodeId=58d785e851a4, content=审稿速度:1.0<br>经验分享：投稿外泌体测序文章，5天拒稿 效率还可以 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13ef5414127, createdName=ms5624929764890046, createdTime=Thu Feb 27 15:51:21 CST 2020, time=2020-02-27, status=1, ipAttribution=)]
    2020-02-27 ms5624929764890046

    审稿速度:1.0
    经验分享：投稿外泌体测序文章，5天拒稿 效率还可以

    0

共38条页码: 1/4页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分

Baidu
Baidu
map
Baidu
map
Baidu
map